Product Highlight - Sitagliptin (SITAZUCA®)

Your ACE in Diabetes Care

• Access – Competitively priced vs. leading brands^1-4
• Confidence – High-quality manufacturing standards (cGMP)⁵
• Efficacy – Efficacious in glycaemic control^6-9

References:
1. MDC and Watsons price survey, Jan 2026.
2. South Star Drug & Watsons online store price check.
3. Xelevia IQVIA Market Data, MAT 2025, Q3.
4. Velmetia IQVIA Market Data, MAT 2025, Q3.
5. cGMP: Current Goods Manufacturing Practice. Philippine FDA, CGMP Certificate No. CDRR-CGMP-2371.
6. Sitagliptin (Sitazuca^®) 50mg & 100mg Product Insert, Version 0, June 2022.
7. Sitagliptin + Metformin Hydrochloride (Sitazuca^® MH) 50mg/500mg and 50mg/1000mg Product Insert, Version 0, January 2023.
8. Aschner P, Katzeff HL, Guo H, et al. Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes. Diabetes Obes Metab. 2010;12(3):252–261.
9. Goldstein BJ, Feinglos MN, Lunceford JK, et al. Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes. Diabetes Care. 2007;30(8):1979–1987.

VIATRIS PHARMACEUTICALS, INC.
22nd Flr Units C&D, Menarco Tower,
32nd St Bonifacio Global City, Taguig City
Phone: (+63-2) 5318 5300
Website: www.viatris.com

Related MIMS Drugs

SITAZUCA